Prosecution Insights
Last updated: August 06, 2026

ETH ZÜRICH

11 pending office actions • 9 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

11
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (73%)
3
Medium (27%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (18%)
§103 only2 (18%)
Double-patenting + other1 (9%)
Multi-statute (no §101)6 (55%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
64% of docket
1
Information Tech
9% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
9% of docket
2
Business / Other
18% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LANE, DANIEL E 1 4.0% +8.5%
KOSHY, JOPHY STEPHEN 1 63.5% +39.0%
PIRO, NICHOLAS ANTHONY 1 41.4% +36.7%
VANWORMER, SKYLAR K 1 45.2% +25.4%
HERNANDEZ, JACKSON J 1 54.0% +31.8%
MERCADO, GABRIEL S 1 42.2% +26.6%
ALLEN, MICHAEL D 1 32.4% +49.2%
CASE, SARAH CATHERINE 1 40.8% +56.3%
NGUYEN, HENRY H 1 64.0% +36.6%
ARMSTRONG, SUSANNAH SIPPLE 1 30.8% +47.5%

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18000242 RNA MOLECULES FOR THE TREATMENT OF CANCER ALLEN, MICHAEL D 183d overdue
17910706 ADDITIVE FOR CEMENT-FREE BUILDING MATERIALS CASE, SARAH CATHERINE 15d overdue
18142195 METHODS AND SYSTEMS FOR GENERATING AND PROVIDING USER INPUT RECOMMENDATIONS FOR RESPONDING TO A RECEIVED MESSAGE MERCADO, GABRIEL S 27d
18001074 SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCER HERNANDEZ, JACKSON J 29d
19103245 METHOD FOR DETERMINING A FATIGUE VALUE OF A PERSON LANE, DANIEL E 42d
18576883 EXTRUDED LEAN MAGNESIUM-CALCIUM ALLOYS KOSHY, JOPHY STEPHEN
18572051 Method for producing calcium carbonate solids from alkaline minerals PIRO, NICHOLAS ANTHONY
18570029 NEURAL NETWORK CIRCUIT FOR DEEP ARTIFICIAL NEURONAL NETWORKS USING DEEP FEEDBACK CONTROL VANWORMER, SKYLAR K

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18000242 RNA MOLECULES FOR THE TREATMENT OF CANCER ALLEN, MICHAEL D 183d overdue
17910706 ADDITIVE FOR CEMENT-FREE BUILDING MATERIALS CASE, SARAH CATHERINE 15d overdue
18142195 METHODS AND SYSTEMS FOR GENERATING AND PROVIDING USER INPUT RECOMMENDATIONS FOR RESPONDING TO A RECEIVED MESSAGE MERCADO, GABRIEL S 27d
18001074 SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCER HERNANDEZ, JACKSON J 29d
18576883 EXTRUDED LEAN MAGNESIUM-CALCIUM ALLOYS KOSHY, JOPHY STEPHEN
18572051 Method for producing calcium carbonate solids from alkaline minerals PIRO, NICHOLAS ANTHONY
18570029 NEURAL NETWORK CIRCUIT FOR DEEP ARTIFICIAL NEURONAL NETWORKS USING DEEP FEEDBACK CONTROL VANWORMER, SKYLAR K
17642776 Biomolecular Detection Device NGUYEN, HENRY H

Top Art Units

Art UnitApps
3715 1
1733 1
1627 1
2171 1
1671 1
1731 1
1758 1
1616 1
1788 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19103245 METHOD FOR DETERMINING A FATIGUE VALUE OF A PERSON LANE, DANIEL E 3715 §101§102§112 Non-Final OA 42d Pending Feb 12, 2025
18576883 EXTRUDED LEAN MAGNESIUM-CALCIUM ALLOYS KOSHY, JOPHY STEPHEN 1733 §103§112 Non-Final OA Pending Jan 05, 2024
18572051 Method for producing calcium carbonate solids from alkaline minerals PIRO, NICHOLAS ANTHONY §102§103§112 Non-Final OA Pending Dec 19, 2023
18570029 NEURAL NETWORK CIRCUIT FOR DEEP ARTIFICIAL NEURONAL NETWORKS USING DEEP FEEDBACK CONTROL VANWORMER, SKYLAR K §103§112 Non-Final OA Pending Dec 13, 2023
18001074 SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCER HERNANDEZ, JACKSON J 1627 §103§112 Final Rejection 29d Pending Jun 22, 2023
18142195 METHODS AND SYSTEMS FOR GENERATING AND PROVIDING USER INPUT RECOMMENDATIONS FOR RESPONDING TO A RECEIVED MESSAGE MERCADO, GABRIEL S 2171 §103§112 Non-Final OA 27d Pending May 02, 2023
18000242 RNA MOLECULES FOR THE TREATMENT OF CANCER ALLEN, MICHAEL D 1671 §101§112 Non-Final OA 183d overdue Pending Nov 29, 2022
17910706 ADDITIVE FOR CEMENT-FREE BUILDING MATERIALS CASE, SARAH CATHERINE 1731 §103§112 Non-Final OA 15d overdue Pending Sep 09, 2022
17642776 Biomolecular Detection Device NGUYEN, HENRY H 1758 §103Other Non-Final OA Pending Mar 14, 2022
17620208 CROSSLINKABLE HYDROGEL COMPOSITIONS ARMSTRONG, SUSANNAH SIPPLE 1616 §103DP Final Rejection Pending Dec 17, 2021
17610979 AEROGEL- AND/OR XEROGEL-BASED MASS FOR ADVANCED MANUFACTURING AND USE THEREOF VO, HAI 1788 §103 Final Rejection Pending Nov 12, 2021

Managing ETH ZÜRICH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month